NCT04999683 is a NA clinical trial of ITIS diet in Rheumatoid Arthritis, sponsored by University of California, San Diego.

Who is sponsoring NCT04999683?

NCT04999683 is sponsored by University of California, San Diego.

What drugs are being tested in NCT04999683?

Interventions in NCT04999683: ITIS diet.

What condition does NCT04999683 study?

NCT04999683 studies Rheumatoid Arthritis, Osteoarthritis.

Is NCT04999683 still recruiting?

NCT04999683 is currently completed. Last updated 1 November 2022.

Last reviewed 2022-11-01 · How we verify

NCT04999683

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Anti-inflammatory (ITIS) Diet in Rheumatoid Arthritis

Completed NA Last updated 1 November 2022

What this trial tests

NA trial testing ITIS diet in Rheumatoid Arthritis in 26 participants. Completed in 1 September 2022.

Timeline

1 September 2018

Primary endpoint
1 September 2021

1 September 2022

Quick facts

Lead sponsor	University of California, San Diego
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	26
Start date	1 September 2018
Primary completion	1 September 2021
Estimated completion	1 September 2022
Sites	1 location across United States

Drugs / interventions tested

ITIS diet

Conditions studied

Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
Osteoarthritis — all drugs for Osteoarthritis →

Sponsor

University of California, San Diego

Who can join

18 and older, any sex, with Rheumatoid Arthritis or Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

to study the effect of anti-inflammatory diet on clinical and biological outcomes in rheumatoid arthritis

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Oxylipin serum profile changes in response to an open-label anti-inflammatory dietary intervention.
Sala-Climent M, Lal E, Cedola F, Alharthi M, et al · · 2025 · cited 1× · PMID 40414498 · DOI 10.1016/j.clnesp.2025.05.027

Verify or expand the search:

Other trials of ITIS diet

Trials testing the same drug.

NCT05559463 — Effect of Anti-inflammatory (ITIS) Diet in Knee Osteoarthritis · NA · recruiting

Other recruiting trials for Rheumatoid Arthritis

Currently open trials in the same condition.

NCT07433335 — A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis · Phase 1 · recruiting
NCT07491016 — Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis · recruiting
NCT07171983 — A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis · Phase 1 · recruiting
NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
NCT07363590 — A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) · Phase 1 · recruiting

Other University of California, San Diego trials

Trials by the same sponsor.

NCT07342543 — Guided Physical Activity Counseling for Hypertension in Primary Care · NA · not yet recruiting
NCT06505317 — Artificial Intelligence for Early Detection of Peripheral Artery Disease · NA · not yet recruiting
NCT07211802 — CKM For Safe Use of SGLT2i in Type 1 Diabetes · Phase 3 · not yet recruiting
NCT07524751 — Culturally Adapted Pain Management for Indigenous Peoples · NA · not yet recruiting
NCT07518784 — Accurate Point of Care Liver Disease Diagnostics (Phase 2) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04999683 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, San Diego
Last refreshed: 1 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04999683.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing